Sun Pharma Unveils Investor Presentation for September 2024, Reports ₹47,758.5 Cr Sales and ₹13,023.1 Cr EBITDA Sept. 30, 2024, 5:32 p.m. Sun Pharmaceutical Industries Limited has released its investor presentation for September 2024.The company operates in over 100 countries and is the largest pharmaceutical company i… Unlock the Full Filing And Lot More Access premium insights and stay ahead of the market with Dzambhala Pro. Learn More